SK99195A3 - Heteroaromatic compounds with antipsychotic effect - Google Patents

Heteroaromatic compounds with antipsychotic effect Download PDF

Info

Publication number
SK99195A3
SK99195A3 SK991-95A SK99195A SK99195A3 SK 99195 A3 SK99195 A3 SK 99195A3 SK 99195 A SK99195 A SK 99195A SK 99195 A3 SK99195 A3 SK 99195A3
Authority
SK
Slovakia
Prior art keywords
formula
piperazinyl
benzisothiazol
butyl
compound
Prior art date
Application number
SK991-95A
Other languages
English (en)
Slovak (sk)
Inventor
Mark H Norman
Frank Navas Iii
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SK99195A3 publication Critical patent/SK99195A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK991-95A 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic effect SK99195A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds
PCT/GB1994/000265 WO1994018196A1 (en) 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic activity

Publications (1)

Publication Number Publication Date
SK99195A3 true SK99195A3 (en) 1995-12-06

Family

ID=10730183

Family Applications (1)

Application Number Title Priority Date Filing Date
SK991-95A SK99195A3 (en) 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic effect

Country Status (15)

Country Link
EP (1) EP0683778A1 (ja)
JP (1) JPH08506337A (ja)
CN (1) CN1117731A (ja)
AU (1) AU6005194A (ja)
BG (1) BG99839A (ja)
CA (1) CA2155758A1 (ja)
CZ (1) CZ204495A3 (ja)
FI (1) FI953777A (ja)
GB (1) GB9302622D0 (ja)
HU (1) HUT73654A (ja)
IL (1) IL108601A0 (ja)
MX (1) MX9401080A (ja)
SK (1) SK99195A3 (ja)
WO (1) WO1994018196A1 (ja)
ZA (1) ZA94891B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
MXPA03004249A (es) * 2000-11-14 2003-09-22 Merck Patent Gmbh Nuevos usos de combinaciones selectivas antagonistas del receptor de dopamina d2 y agonistas del receptor de 5-ht1a.
JP4497815B2 (ja) * 2001-02-16 2010-07-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド 新規な複素環式アミド誘導体およびドーパミンｄ３受容体リガンドとしてのその使用
CA2455621C (en) 2001-07-26 2010-11-16 Merck Patent Gesellschaft Mit Beschraenkter Haftung Use of (r/s)-(-/+) or (s)-(+)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane for the treatment of extrapyramidal movement disorders
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
CN101018774A (zh) * 2004-07-20 2007-08-15 锡耶纳生物技术股份公司 α7烟碱性乙酰胆碱受体的调节剂和其治疗用途
CL2008000119A1 (es) 2007-01-16 2008-05-16 Wyeth Corp Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.

Also Published As

Publication number Publication date
AU6005194A (en) 1994-08-29
EP0683778A1 (en) 1995-11-29
WO1994018196A1 (en) 1994-08-18
GB9302622D0 (en) 1993-03-24
HUT73654A (en) 1996-09-30
CA2155758A1 (en) 1994-08-18
CN1117731A (zh) 1996-02-28
IL108601A0 (en) 1994-05-30
FI953777A0 (fi) 1995-08-09
MX9401080A (es) 1994-08-31
CZ204495A3 (en) 1996-03-13
JPH08506337A (ja) 1996-07-09
ZA94891B (en) 1995-08-10
BG99839A (bg) 1996-02-28
HU9501881D0 (en) 1995-08-28
FI953777A (fi) 1995-08-09

Similar Documents

Publication Publication Date Title
EP1954696B1 (en) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
SK96494A3 (en) Piperazine and piperidine derivatives, and their use as antipsychotic
JP3886897B2 (ja) ベンゾチアゾール誘導体
FI91868B (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
US8604050B2 (en) Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
EP1833836B1 (en) Imidazo-fused thiazolo [4,5-b] pyridine based tricyclic compounds and pharmaceutical compositions comprising same
CA2567703C (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
JP4244189B2 (ja) アデノシン受容体リガンドとしての７−アミノ−ベンゾチアゾール誘導体
SK99195A3 (en) Heteroaromatic compounds with antipsychotic effect
WO2007038669A9 (en) Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
CZ300709B6 (cs) 5-Pyridyl-1,3-azolové slouceniny, zpusob výroby a použití
EP0682656A1 (en) Use of phenyl heteroaryl ureas as 5ht 2c? receptor antagonists and urea compounds
RU2295523C2 (ru) Производные бензотиазола в качестве лигандов рецептора аденозина и лекарственное средство
JP2000511534A (ja) ベンゾオキサジノンドーパミンｄ４受容体アンタゴニスト
US5071864A (en) Aminoalkyl-substituted 2-aminothiazoles and therapeutic agents containing them
KR100699615B1 (ko) 벤족사졸 유도체 및 아데노신 수용체 리간드로서의 이들의용도
JP4283116B2 (ja) ベンゾチアゾール
Walczyński et al. Histamine H1 receptor ligands: Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology
CN101346385A (zh) 新化合物
AU2006327981A1 (en) Thienopyridine derivatives as modulators of metabotropic glutamate receptors
JPS61205275A (ja) 新規の８‐チオテトラヒドロキノリン誘導体及びそれらの塩
KR100581703B1 (ko) 아데노신 수용체 조절제로서의 벤조티오펜